©The Author(s) 2020.
World J Clin Cases. May 26, 2020; 8(10): 1887-1896
Published online May 26, 2020. doi: 10.12998/wjcc.v8.i10.1887
Published online May 26, 2020. doi: 10.12998/wjcc.v8.i10.1887
Table 2 Serum tumor markers and medical imaging examinations of pelvic leiomyosarcoma patients
| Characteristic | Uterine leiomyosarcoma (n = 35) | Non-uterine leiomyosarcoma (n = 16) |
| Serum tumor markers, n (%) | ||
| CA125 | 21 (60) | 11 (68.8) |
| Elevated | 6 (28.6) | 5 (45.5) |
| Not elevated | 15 (71.4) | 6 (54.5) |
| CEA | 15 (42.9) | 7 (63.6) |
| Elevated | 1 (6.7) | 0 (0) |
| Not elevated | 14 (93.3) | 7 (100) |
| AFP | 14 (40) | 7 (63.6) |
| Elevated | 0 (0) | 0 (0) |
| Not elevated | 14 (100) | 7 (100) |
| CA199 | 12 (34.3) | 7 (63.6) |
| Elevated | 0 (0) | 0 (0) |
| Not elevated | 12 (100) | 7 (100) |
| CA153 | 5 (14.3) | 0 (0) |
| Elevated | 0 (0) | — |
| Not elevated | 5 (100) | — |
| CA724 | 5 (14.3) | 0 (0) |
| Elevated | 2 (40) | — |
| Not elevated | 3 (60) | — |
| Medical imaging examination, n (%) | ||
| Ultrasonography | 16 (45.7) | 11 (68.8) |
| Hysteromyoma | 11 (68.8) | 1 (9.1) |
| Pelvic and abdominal mass | 4 (25) | 8 (72.7) |
| Malignant occupancy of cervix | 1 (6.2) | 2 (18.2) |
| CT | 2 (5.7) | 1 (6.3) |
| MRI | 1 (2.9) | 0 (0) |
- Citation: Sun Q, Yang X, Zeng Z, Wei X, Li KZ, Xu XY. Outcomes of patients with pelvic leiomyosarcoma treated by surgery and relevant auxiliary diagnosis. World J Clin Cases 2020; 8(10): 1887-1896
- URL: https://www.wjgnet.com/2307-8960/full/v8/i10/1887.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i10.1887